Knowledge Translation (and Exchange) for Vaccine-Preventable Diseases (VPDs)

CPHA Conference May 27 th , 2014 Lisa Paddle, Nurse Advisor

2 KTE on Vaccine-Preventable Diseases

Presentation Outline

 What is Knowledge Translation and Exchange (KTE) and why is it important?

     KTE in context of Vaccine-Preventable Disease Surveillance The ‘right’ audience The ‘right’ time The ‘right’ tools Additional Learning Resources/KTE Mechanisms

3 KTE on Vaccine-Preventable Diseases

What is knowledge translation (KT) / exchange (KTE)?

 “a dynamic and iterative process that includes synthesis, dissemination, exchange and ethically-sound application of knowledge to improve the health of Canadians, provide more effective health services and products and strengthen the health care system” (Source:

Canadian Institutes of Health Research)

 This process takes place within a complex system of interactions between researchers and knowledge users that vary in intensity, complexity and level of engagement depending on the nature of the research and the findings as well as the needs of the particular knowledge user

4 KTE on Vaccine-Preventable Diseases

Knowledge Translation Models

    Based on 31 planned action theories Designed to be used by broad range of audiences Key is importance of appropriate relationships Fluid, non-linear

5 KTE on Vaccine-Preventable Diseases

Knowledge translation

is about the application and use of the best available science to benefit health and well being.

Knowledge output Knowledge uptake/ impact The right information to the right people in the right way at the right time

6 KTE on Vaccine-Preventable Diseases

VPD Surveillance: How to translate science to knowledge

KTE on Vaccine-Preventable Diseases

Who were our key surveillance stakeholders?

Professional organizations:

•Canadian Paediatric Society (CPS) •Immunize Canada •Society for Obstetricians &

International organizations:

•Centres for Disease Control & Prevention (CDC) •Pan-American Health

Government:

•PHAC (other Centres & Divisions) •National Microbiology Laboratory (NML) •Health Canada (First Gynaecologists (SOGC) •Canadian Public Health Association (CPHA) •Etc.

Organization (PAHO) •World Health Organization (WHO) Nations, Vaccine Regulation) •Provincial / Territorial (P/T) VPD / immunization programs

Immunization providers:

•Local public health units •Primary health providers •Hospitals •Long-Term Care Homes •Occupational health services Immunization and Respiratory Infectious Diseases

Research community:

•Canadian Association of Immunization research and Evaluation (CAIRE) •PHAC-CIHR Influenza Research Network (PCIRN) •Vaccine evaluation centres •IMPACT •Individual researchers & students

F-P-T / Expert Committees:

•Canadian Immunization Committee (CIC) •National Advisory Committee on Immunization (NACI) •Committee to Advise on Tropical Medicine and Travel (CATMAT)

General public:

•Individuals / parents •Media •Public advocacy groups 7

8 KTE on Vaccine-Preventable Diseases

What was our key mechanism?

9 KTE on Vaccine-Preventable Diseases

Objectives of Vaccine-Preventable Disease Surveillance

 To provide

timely, quality

national surveillance data to

detect trends

in disease incidence 

To provide information

to support program planning and evaluation, outbreak response and future policy and program decision-making  To

increase knowledge and understanding

research of the epidemiology of vaccine preventable diseases through innovative enhanced surveillance systems and

KTE on Vaccine-Preventable Diseases

Goal of Knowledge Translation in the Context of VPD Surveillance

To align national VPD surveillance products with the information needs of key partners & stakeholders and effectively (and efficiently) inform immunization and vaccine-preventable disease program decisions. 10 VPD’s include: Invasive meningococcal disease (IMD) Varicella Invasive pneumococcal disease (IPD) Polio Pertussis Measles Mumps Rubella Diphtheria Tetanus Haemophilus influenza disease GBS/iGAS*

KTE on Vaccine-Preventable Diseases

KTE Strategy for Vaccine-Preventable Disease Surveillance

      Notifiable Diseases On-line for aggregate case counts at the national level Routine cycle for publication of surveillance reports up to 2023

(Canada Communicable Disease Reports)

   Q1 (Polio/AFP; measles; rubella; CRS) Q2 years (IMD) Q 5 years (Invasive Bacterial Diseases including Hi, IPD, iGBS, iGAS, International Circumpolar Surveillance, Pertussis)  Exploring options around

weekly

online measles reports VPD surveillance on

Agency Website

 All products (e.g. Canadian Immunization Guide) will “point” here.

National Advisory Committee on Immunization

(NACI) Statements

 For product or strain-specific epidemiologic analysis Peer Review journals for specific level of analysis Disease Guidelines for epidemiologic summaries 11

Out with the Old, in with the New

Government of Canada Web Renewal Action Plan (GCWRAP)

     

www.Canada.ca

by the end of 2016 One website User-centric Modernized, leaner Accessible (hand-held devices as well as assistive technologies) Resources +

“This single site (Canada.ca) approach will require that the Government of Canada fundamentally transform its web presence to better meet the needs of Canadians by being user centric.”

12

Website Renewal: Out with the Old, in with the New

Immunization and Vaccines Landing Page (before)

13

KTE on Vaccine-Preventable Diseases Immunization and Vaccines Landing Page (After) 14 http://www.phac-aspc.gc.ca/im/index-eng.php

KTE on Vaccine-Preventable Diseases

New Vaccine-Preventable Diseases Landing Pages

        General Public (plain language) AND Health Professional audiences De-duplication Audience-specific Organized and easy to navigate Hyperlinks to relevant content Images/sounds, as appropriate Surveillance section : How is surveillance done on this VPD in Canada?

Health Professionals: information and resources specific to Health Professionals 15

KTE on Vaccine-Preventable Diseases

Select KTE Learning Resources

     PHAC Knowledge Translation Primer ( http://publications.gc.ca/collections/collection_2013/aspc-phac/HP35-37 2012-eng.pdf

) National Collaborating Centre for Methods and Tools ( http://www.nccmt.ca/ ) CIHR: Population and Public Health Institute ( http://www.cihr irsc.gc.ca/e/27155.html

)  KT Clearinghouse: www.ktclearinghouse.ca Institute for Knowledge Mobilization ( www.knowledgemobilization,net ) Health Evidence ( www.health-evidence.org

)

Some KTE mechanisms for Vaccine-Preventable diseases

Public Health Agency of Canada Website: Immunization and Vaccines Canadian Immunization Guide Canada Communicable Disease Reports (CCDR) CNPHI (Canadian Network for Public Health Intelligence) (Public Health Alerts) 16

KTE on Vaccine-Preventable Diseases

Acknowledgements

  Heather Deehan, Chief Vaccine Preventable Diseases (PHAC) Anita Li, Tiffany Smith, Amanda Shane, Lindsey Sherrard, Epidemiologists VPD section (PHAC)    Dr. Shalini Desai, Medical Specialist (PHAC) Nadine Abboud, Project Management Support (PHAC) Monique St-Laurent, A/Director Vaccine and Immunization Program Surveillance Division (PHAC)  Dr. John Spika, Director General, Centre for Immunization and Respiratory Infectious Diseases (CIRID) (PHAC)   Robert Lerch, Oliver Baclic, Althea House, CIG secretariat (PHAC) Tara Harris, Public Health Ontario(formerly PHAC) 17